# Repurposing of Chlorpromazine in Covid-19 Treatment

> **NCT04366739** · PHASE3 · WITHDRAWN · sponsor: **Centre Hospitalier St Anne**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** CHLORPROMAZINE (CPZ)
- **COMBINATION_PRODUCT:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT04366739
- **Lead sponsor:** Centre Hospitalier St Anne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-29
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No favourable opinion obtained from the Ethics Committee
- **Last updated:** 2024-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04366739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04366739, "Repurposing of Chlorpromazine in Covid-19 Treatment". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT04366739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*